A Study of ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis

Clinical trial NCT03358030 · COMPLETED

Trial details

NCT number: NCT03358030
Sponsor: Ionis Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

End-stage Renal Disease (ESRD)

Start date: 2017-12-26
Primary completion: 2019-07-10
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.